Wird geladen...
Improvement of platelet dysfunction in chronic myelogenous leukemia following treatment with imatinib: a case report
INTRODUCTION: In patients with chronic myeloid leukemia, tyrosine kinase inhibitors suppress the BCR-ABL(+ )clone and often induce complete molecular remissions. Megakaryocytes in such patients have been shown to be derived from the BCR-ABL(+ )clone, and abnormal platelet function is frequent in chr...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2011
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3117828/ https://ncbi.nlm.nih.gov/pubmed/21624109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-5-215 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|